SHR-4610

SHR-4610 · Shanghai Shengdi Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-4610, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]